Cite
HARVARD Citation
Guzauskas, G. et al. (n.d.). HOUT-18. COST EFFECTIVENESS OF TREATING GLIOBLASTOMA PATIENTS AGE 65 YEARS OR OLDER WITH TUMOR TREATING FIELDS PLUS TEMOZOLOMIDE VERSUS TEMOZOLOMIDE ALONE. Neuro-oncology. pp. vi116-vi117. [Online].